Table 2. Clinical chemistry parameters.
| γ(parameter)/(mg/100 mL) | G1 | G2 | G3 | G4 | G5 | G6 | G7 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLU | 180±220 | 217±24 | 169±23 | 206±62 | 206±40 | 198±25 | 215±69 | |||||||
| CHO | (70.9±7.8)a | 124.6±9.9 | 114±27 | 131±40 | 115±18 | 118±20 | 120±25 | |||||||
| TRI | 48±15 | 64±22 | 70±17 | 81±25 | 94±39 | 85±22 | 76±25 | |||||||
| HDL | (38.5±5.4)a | 63.3±3.4 | 56.0±12.6 | 62.8±19.4 | 59.0±11.0 | 60.5±10.6 | 54.6±18.1 | |||||||
| LDL | 3.0±0.4 | 4.5±0.7 | 5.5±3.1 | 4.4±1.9 | 4.7±0.7 | 4.6±1.1 | 6.6±4.9 | |||||||
| URE | 43.2±6.3 | 48.3±7.8 | 50.6±5.5 | 52.8±3.4 | 50.4±5.6 | 55.1±7.4 | 53.3±5.2 | |||||||
| CRE | 0.38±0.03 | 0.38±0.02 | 0.36±0.02 | 0.37±0.02 | 0.39±0.02 | 0.39±0.02 | 0.40±0.01 | |||||||
| N(parameter)/(U/L) | ||||||||||||||
| AST | 71±22 | 132±72 | 88±37 | 176±89 | 92±40 | 110±51 | 126±62 | |||||||
| ALT | 33.6±1.6 | 44±12 | 31±13 | 48±11 | 33±5 | 33.2±6.2 | 36±14 | |||||||
Values are expressed as mean±standard deviation (N=10). aIndicates statistically significant differences (p<0.05) with respect to G2. G1=normal control, G2=HFD control, G3=HFD+capsanthin-enriched pellets (low dose), G4=HFD+capsanthin-enriched pellets (medium dose), G5=HFD+capsanthin-enriched pellets (high dose), G6=HFD+capsaicin pellets, G7=HFD+orlistat, HFD=high fat diet, S.D.=standard deviation, Glu=glucose, CHO=cholesterol, TRIG=triglycerides, HDL=high density lipoprotein, LDL=low density lipoprotein, URE=urea, CRT=creatinine, AST=aspartate aminotransferase, ALT=alanine aminotransferase, TP=total protein, ALB=albumin, ALP=alkaline phosphatase